Among secondary outcomes, all-cause mortality was higher in the SOTR group (10.0% vs 2.5%, P = .066), although the difference did not reach statistical significance.
← all excerpts
Clinical Outcome of Rifabutin-based Treatment for Pulmonary Tuberculosis in Solid Organ Transplant Recipients.
1
—
—